![]() |
市場調査レポート
商品コード
1386203
A型肝炎ワクチン市場レポート:2030年までの動向、予測、競合分析Hepatitis A Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
A型肝炎ワクチン市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
世界のA型肝炎ワクチン市場は、2024年から2030年までのCAGRが3.6%で、2030年までに推定10億米ドルに達すると予想されます。この市場の主な促進要因は、予防接種の重要性に対する意識の高まり、A型肝炎の蔓延を抑制するための政府の支援策、新興国での医療インフラの整備が進んでいることです。世界のA型肝炎ワクチン市場の将来は、政府機関や民間の市場にビジネスチャンスがあり、有望視されています。
Lucintelの予測では、弱毒生ワクチンは自然感染を予防し、強力かつ長期的な免疫反応を構築するために広く使用されているため、予測期間中に高い成長が見込まれます。
この市場の中では、政府機関が予測期間中に高い成長を示すことが期待されています。
アジア太平洋は、継続的な人口増加とA型肝炎感染者数の増加により、予測期間中に最も高い成長が見込まれます。
市場規模・推定:A型肝炎ワクチンの市場規模を金額(10億米ドル)で推定。
動向と予測分析:各種セグメント別、地域別の市場動向(2018年~2023年)と予測(2024年~2030年)。
市場セグメンテーション分析:a型肝炎ワクチン市場規模をタイプ別、用途別、地域別に金額(10億米ドル)で推定
地域分析:a型肝炎ワクチン市場の北米、欧州、アジア太平洋、その他世界の地域内訳。
成長機会:A型肝炎ワクチン市場のタイプ別、用途別、地域別の成長機会分析。
戦略分析:A型肝炎ワクチン市場のM&A、新製品開発、競合情勢など。
ポーターのファイブフォースモデルに基づく業界の競合強度分析。
The future of the global hepatitis A vaccine market looks promising with opportunities in the government institution and private sector markets. The global hepatitis A vaccine market is expected to reach an estimated $1.0 billion by 2030 with a CAGR of 3.6% from 2024 to 2030. The major drivers for this market are rising awareness about the importance of immunization, supportive government initiatives to control the spread of hepatitis A, and growing healthcare infrastructure in developing countries.
A more than 150-page report is developed to help in your business decisions.
The study includes a forecast for the global hepatitis A vaccine by type, application, and region.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hepatitis A vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hepatitis A vaccine companies profiled in this report include-
Lucintel forecasts that live attenuated vaccine is expected to witness higher growth over the forecast period due to its widespread usage to prevent natural infection and build a strong and long-lasting immune response.
Within this market, government institution is expected to witness higher growth over the forecast period.
APAC is expected to witness highest growth over the forecast period due to continous growth of population base and rising number of hepatitis A infection affected population in the region.
Market Size Estimates: Hepatitis a vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Hepatitis a vaccine market size by type, application, and region in terms of value ($B).
Regional Analysis: Hepatitis a vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the hepatitis A vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hepatitis A vaccine market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Answer: The global hepatitis A vaccine market is expected to reach an estimated $1.0 billion by 2030.
Answer: The global hepatitis A vaccine market is expected to grow with a CAGR of 3.6% from 2024 to 2030.
Answer: The major drivers for this market are rising awareness about the importance of immunization, supportive government initiatives to control the spread of hepatitis A, and growing healthcare infrastructure in developing countries.
Answer: The future of the hepatitis A vaccine market looks promising with opportunities in the government institution and private sector markets.
Answer: Some of the key hepatitis A vaccine companies are as follows:
Answer: Lucintel forecasts that live attenuated vaccine is expected to witness higher growth over the forecast period due to its widespread usage to prevent natural infection and build a strong and long-lasting immune response.
Answer: APAC is expected to witness highest growth over the forecast period due to continous growth of population base and rising number of hepatitis A infection affected population in the region.
Answer: Yes, Lucintel provides 10% customization without any additional cost.